View ValuationElbstein 将来の成長Future 基準チェック /06現在、 Elbsteinの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Capital Markets 収益成長6.9%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 21Elbstein AG, Annual General Meeting, May 29, 2026Elbstein AG, Annual General Meeting, May 29, 2026, at 10:00 W. Europe Standard Time.Buy Or Sell Opportunity • Mar 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 33% to €0.70. The fair value is estimated to be €0.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Buy Or Sell Opportunity • Feb 05Now 24% overvaluedOver the last 90 days, the stock has fallen 8.3% to €1.10. The fair value is estimated to be €0.89, however this is not to be taken as a sell recommendation but rather should be used as a guide only.お知らせ • Aug 13Elbstein AG, Annual General Meeting, Sep 19, 2025Elbstein AG, Annual General Meeting, Sep 19, 2025, at 11:00 W. Europe Standard Time.Buy Or Sell Opportunity • Aug 12Now 73% overvalued after recent price riseOver the last 90 days, the stock has risen 190% to €1.45. The fair value is estimated to be €0.84, however this is not to be taken as a sell recommendation but rather should be used as a guide only.Buy Or Sell Opportunity • Jul 09Now 44% overvalued after recent price riseOver the last 90 days, the stock has risen 138% to €1.19. The fair value is estimated to be €0.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only.New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risk Market cap is less than US$100m (€13.5m market cap, or US$15.9m).New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (€110k revenue, or US$114k). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (€15.0m market cap, or US$15.6m).お知らせ • Jul 29Elbstein AG, Annual General Meeting, Sep 04, 2024Elbstein AG, Annual General Meeting, Sep 04, 2024, at 11:00 W. Europe Standard Time.New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (42% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€21.0m market cap, or US$22.5m).New Risk • May 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Revenue has declined by 98% over the past year. Revenue is less than US$1m (€2.4k revenue, or US$2.6k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€15.0m market cap, or US$16.3m).Buy Or Sell Opportunity • May 22Now 32% undervalued after recent price dropOver the last 90 days, the stock has fallen 2.0% to €0.50. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Feb 02Now 30% undervaluedOver the last 90 days, the stock has risen 34% to €0.51. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.Buying Opportunity • Jan 11Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.New Risk • Dec 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.50m (US$8.06m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (43% average weekly change). Market cap is less than US$10m (€7.50m market cap, or US$8.06m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Buying Opportunity • Nov 18Now 54% undervalued after recent price dropOver the last 90 days, the stock is down 25%. The fair value is estimated to be €0.82, however this is not to be taken as a buy recommendation but rather should be used as a guide only.New Risk • Oct 12New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.30m (US$9.81m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (18% average weekly change). Market cap is less than US$10m (€9.30m market cap, or US$9.81m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Buying Opportunity • Aug 01Now 27% undervalued after recent price dropOver the last 90 days, the stock is down 65%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only.Buying Opportunity • Jul 12Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 62%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only.New Risk • Jul 02New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€27.0m market cap, or US$29.5m).Buying Opportunity • Jun 15Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 62%. The fair value is estimated to be €0.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 96% over the last year. Earnings per share has declined by 33%.Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €1.20, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 17x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years.Valuation Update With 7 Day Price Move • Apr 26Investor sentiment improves as stock rises 30%After last week's 30% share price gain to €1.30, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total loss to shareholders of 9.8% over the past three years.Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €1.54, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years.Valuation Update With 7 Day Price Move • Jan 18Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €1.15, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 23% over the past three years.Valuation Update With 7 Day Price Move • Dec 06Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to €1.21, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 17% over the past three years.Valuation Update With 7 Day Price Move • Oct 06Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €1.50, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 4.1% over the past three years.Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to €1.60, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 10% over the past three years.Valuation Update With 7 Day Price Move • Sep 02Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to €1.55, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 6.9% over the past three years.Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.20, the stock trades at a trailing P/E ratio of 34.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 50% over the past three years.Valuation Update With 7 Day Price Move • May 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.06, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 14x in the Capital Markets industry in Germany. Total returns to shareholders of 46% over the past three years.Valuation Update With 7 Day Price Move • Dec 02Investor sentiment deteriorated over the past weekAfter last week's 28% share price decline to €2.10, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 16x in the Capital Markets industry in Germany. Total returns to shareholders of 66% over the past three years.Upcoming Dividend • Aug 20Upcoming dividend of €0.05 per shareEligible shareholders must have bought the stock before 27 August 2021. Payment date: 31 August 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (2.5%).Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to €2.90, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 20x in the Capital Markets industry in Germany. Total returns to shareholders of 99% over the past three years.分析記事 • Jul 02Unpleasant Surprises Could Be In Store For Elbstein AG's (HMSE:EBS) SharesWith a median price-to-earnings (or "P/E") ratio of close to 26x in Germany, you could be forgiven for feeling...Reported Earnings • Jun 29Full year 2020 earnings releasedThe company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: €3.52m (up €3.11m from FY 2019). Net income: €2.83m (up 273% from FY 2019). Profit margin: 80% (down from 186% in FY 2019). The decrease in margin was primarily driven by higher revenue.Valuation Update With 7 Day Price Move • Mar 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €2.00, the stock is trading at a trailing P/E ratio of 52.8x, down from the previous P/E ratio of 62.8x. This compares to an average P/E of 21x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 56%.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €2.20, the stock is trading at a trailing P/E ratio of 58x, down from the previous P/E ratio of 68.6x. This compares to an average P/E of 19x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 79%.Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.20, the stock is trading at a trailing P/E ratio of 58x, up from the previous P/E ratio of 48.8x. This compares to an average P/E of 17x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 71%.Is New 90 Day High Low • Jan 15New 90-day high: €2.04The company is up 40% from its price of €1.46 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 11% over the same period.Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 33% share price gain to €2.00, the stock is trading at a trailing P/E ratio of 5.3x, up from the previous P/E ratio of 4x. This compares to an average P/E of 15x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 52%.Is New 90 Day High Low • Oct 02New 90-day low: €14.50The company is down 6.0% from its price of €15.50 on 03 July 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is down 10.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Elbstein は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測HMSE:EBS - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20230-1N/AN/AN/A12/31/20220-23N/AN/AN/A12/31/202102N/AN/AN/A12/31/202043N/AN/AN/A12/31/201901N/AN/AN/A12/31/201811N/AN/AN/A12/31/201722N/AN/AN/A12/31/201601N/AN/AN/A12/31/201511N/AN/AN/Aアナリストによる今後の成長予測収入対貯蓄率: EBSの予測収益成長が 貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: EBSの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: EBSの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: EBSの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: EBSの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: EBSの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YDiversified-financials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/07 00:09終値2026/05/07 00:00収益2023/12/31年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Elbstein AG 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 21Elbstein AG, Annual General Meeting, May 29, 2026Elbstein AG, Annual General Meeting, May 29, 2026, at 10:00 W. Europe Standard Time.
Buy Or Sell Opportunity • Mar 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 33% to €0.70. The fair value is estimated to be €0.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Buy Or Sell Opportunity • Feb 05Now 24% overvaluedOver the last 90 days, the stock has fallen 8.3% to €1.10. The fair value is estimated to be €0.89, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
お知らせ • Aug 13Elbstein AG, Annual General Meeting, Sep 19, 2025Elbstein AG, Annual General Meeting, Sep 19, 2025, at 11:00 W. Europe Standard Time.
Buy Or Sell Opportunity • Aug 12Now 73% overvalued after recent price riseOver the last 90 days, the stock has risen 190% to €1.45. The fair value is estimated to be €0.84, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
Buy Or Sell Opportunity • Jul 09Now 44% overvalued after recent price riseOver the last 90 days, the stock has risen 138% to €1.19. The fair value is estimated to be €0.83, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risk Market cap is less than US$100m (€13.5m market cap, or US$15.9m).
New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (€110k revenue, or US$114k). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (€15.0m market cap, or US$15.6m).
お知らせ • Jul 29Elbstein AG, Annual General Meeting, Sep 04, 2024Elbstein AG, Annual General Meeting, Sep 04, 2024, at 11:00 W. Europe Standard Time.
New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (42% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€21.0m market cap, or US$22.5m).
New Risk • May 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Revenue has declined by 98% over the past year. Revenue is less than US$1m (€2.4k revenue, or US$2.6k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€15.0m market cap, or US$16.3m).
Buy Or Sell Opportunity • May 22Now 32% undervalued after recent price dropOver the last 90 days, the stock has fallen 2.0% to €0.50. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Feb 02Now 30% undervaluedOver the last 90 days, the stock has risen 34% to €0.51. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.
Buying Opportunity • Jan 11Now 30% undervalued after recent price dropOver the last 90 days, the stock is down 7.3%. The fair value is estimated to be €0.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 98% over the last year. Meanwhile, the company became loss making.
New Risk • Dec 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.50m (US$8.06m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (43% average weekly change). Market cap is less than US$10m (€7.50m market cap, or US$8.06m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Buying Opportunity • Nov 18Now 54% undervalued after recent price dropOver the last 90 days, the stock is down 25%. The fair value is estimated to be €0.82, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
New Risk • Oct 12New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.30m (US$9.81m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2021 fiscal period end). Share price has been highly volatile over the past 3 months (18% average weekly change). Market cap is less than US$10m (€9.30m market cap, or US$9.81m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Buying Opportunity • Aug 01Now 27% undervalued after recent price dropOver the last 90 days, the stock is down 65%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
Buying Opportunity • Jul 12Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 62%. The fair value is estimated to be €0.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
New Risk • Jul 02New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€27.0m market cap, or US$29.5m).
Buying Opportunity • Jun 15Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 62%. The fair value is estimated to be €0.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 96% over the last year. Earnings per share has declined by 33%.
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €1.20, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 17x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years.
Valuation Update With 7 Day Price Move • Apr 26Investor sentiment improves as stock rises 30%After last week's 30% share price gain to €1.30, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total loss to shareholders of 9.8% over the past three years.
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to €1.54, the stock trades at a trailing P/E ratio of 24.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total loss to shareholders of 16% over the past three years.
Valuation Update With 7 Day Price Move • Jan 18Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to €1.15, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 23% over the past three years.
Valuation Update With 7 Day Price Move • Dec 06Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to €1.21, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 17% over the past three years.
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €1.50, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 4.1% over the past three years.
Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to €1.60, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 10% over the past three years.
Valuation Update With 7 Day Price Move • Sep 02Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to €1.55, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 6.9% over the past three years.
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.20, the stock trades at a trailing P/E ratio of 34.6x. Average trailing P/E is 11x in the Capital Markets industry in Germany. Total returns to shareholders of 50% over the past three years.
Valuation Update With 7 Day Price Move • May 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.06, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 14x in the Capital Markets industry in Germany. Total returns to shareholders of 46% over the past three years.
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment deteriorated over the past weekAfter last week's 28% share price decline to €2.10, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 16x in the Capital Markets industry in Germany. Total returns to shareholders of 66% over the past three years.
Upcoming Dividend • Aug 20Upcoming dividend of €0.05 per shareEligible shareholders must have bought the stock before 27 August 2021. Payment date: 31 August 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (2.5%).
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to €2.90, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 20x in the Capital Markets industry in Germany. Total returns to shareholders of 99% over the past three years.
分析記事 • Jul 02Unpleasant Surprises Could Be In Store For Elbstein AG's (HMSE:EBS) SharesWith a median price-to-earnings (or "P/E") ratio of close to 26x in Germany, you could be forgiven for feeling...
Reported Earnings • Jun 29Full year 2020 earnings releasedThe company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: €3.52m (up €3.11m from FY 2019). Net income: €2.83m (up 273% from FY 2019). Profit margin: 80% (down from 186% in FY 2019). The decrease in margin was primarily driven by higher revenue.
Valuation Update With 7 Day Price Move • Mar 05Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €2.00, the stock is trading at a trailing P/E ratio of 52.8x, down from the previous P/E ratio of 62.8x. This compares to an average P/E of 21x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 56%.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €2.20, the stock is trading at a trailing P/E ratio of 58x, down from the previous P/E ratio of 68.6x. This compares to an average P/E of 19x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 79%.
Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.20, the stock is trading at a trailing P/E ratio of 58x, up from the previous P/E ratio of 48.8x. This compares to an average P/E of 17x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 71%.
Is New 90 Day High Low • Jan 15New 90-day high: €2.04The company is up 40% from its price of €1.46 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 11% over the same period.
Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 33% share price gain to €2.00, the stock is trading at a trailing P/E ratio of 5.3x, up from the previous P/E ratio of 4x. This compares to an average P/E of 15x in the Capital Markets industry in Germany. Total returns to shareholders over the past three years are 52%.
Is New 90 Day High Low • Oct 02New 90-day low: €14.50The company is down 6.0% from its price of €15.50 on 03 July 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is down 10.0% over the same period.